Management Team

Ruben Krupik

Chief Executive Officer

In addition to his position as CEO, Ruben is responsible for defining the vision, strategy and direction of the Company. Ruben serves as active chairman in D-pharm, CureTech, Mediwound and Andromeda.

An accomplished, multi-disciplinary industry executive and visionary, Ruben was a key driver in the launch of numerous successful companies in the fields of medical technology (Given Imaging, Galil Medical), image processing (3DV), broadband and software. With a wide-ranging entrepreneurial track record, he is well experienced in the complex process of transforming promising ideas into thriving companies.
He served as President and CEO of RDC, which specializes in identifying commercially viable technologies within Rafael and forming start-up companies around them. Formerly, Ruben held senior positions in Tadiran Telecommunication Group where he accrued extensive experience in high-tech management.

Ruben holds an LLB from the Faculty of Law of the Tel Aviv University and B.A.s in Economics and Political Science both from the Hebrew University of Jerusalem.


 

Ruben Krupik, CEO
 

Ofer Goldberg, Vice President
 

Ofer Gonen, Vice President
 

Amos Bankirer, Vice President
 

Nitsa Einan, Legal Counsel
 

Gil Milner, CFO
  Board Members

 

Avi Fischer - Chairman of the Board
 

Dr. Aharon Schwartz
 

Dr. Gabi Barabash
 

Dr. Tamar Manor
 

Dr. Udi Raanani
 

Avi Zigelman
 

Yoni Kaplan
 
 
  Home | Profile | Team | Portfolio | Contact Us | Disclaimer All Rights Reserved to Clal Biotechnology Industries Ltd.